Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Breast-Conserving Surgery Techniques in Treating Women With Breast Cancer [Phase 2]
An update on a Phase 2 clinical trial evaluating breast-conserving surgery techniques for women with breast cancer; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy [Phase 3]
Phase 3 randomized, placebo-controlled trial evaluating glutamine for peripheral neuropathy in breast cancer patients; the study has complet…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Preventing Sexual Dysfunction With Aromatase Inhibitors [Phase 2]
A Phase 2 clinical trial at MD Anderson explored preventing sexual dysfunction in patients receiving aromatase inhibitors for breast cancer;…
-
CLINICAL_TRIALS research · 2017-08-18Clinical Trial Update: Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics/pharmacodynamics of GW003 in breast cancer patients, with c…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
This study reports on quality of life, employment, and informal caregiver costs for women undergoing chemotherapy for breast cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer [Phase 2]
Phase 2 trial evaluating metformin to reduce paclitaxel-related neuropathy in breast cancer; the study was terminated and results were poste…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer [Phase 1]
This Phase 1 trial update reports results for a NY-ESO-1 vaccine with the GLA-SE adjuvant in patients with unresectable or metastatic cancer…
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer [Phase 2]
Phase 2 trial results evaluate the combination of paclitaxel and capecitabine in women with metastatic breast cancer.
-
CLINICAL_TRIALS withdrawal · 2017-08-16Clinical Trial Update: A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease. [Phase 2]
Phase 2 trial of intravenous ibandronate (Bondronat) in breast cancer patients with metastatic bone disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics [NA]
A completed trial evaluated flaxseed in combination with aromatase inhibitors and its effect on breast tumor characteristics. The results we…
-
CLINICAL_TRIALS withdrawal · 2017-08-16Clinical Trial Update: Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn [Phase 4]
A Phase 4 clinical trial evaluating ketorolac for analgesia after autologous breast reconstruction has been withdrawn.
-
CLINICAL_TRIALS research · 2017-08-16Clinical Trial Update: Halaven Patient Registry (Metastatic Breast Cancer, MBC)
A clinical trial registry update for the Halaven (eribulin mesylate) patient registry in metastatic and advanced breast cancer, sponsored by…
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluated a novel capecitabine dosing schedule in combination with lapatinib for HER2-positive, trastuzumab-refractory metas…
-
CLINICAL_TRIALS research · 2017-08-15Clinical Trial Update: Simulating Outcomes From Breast Conserving Surgery Using 3D Surface Imaging [NA]
This entry provides an update on a clinical trial investigating the use of 3D surface imaging to simulate outcomes after breast-conserving s…
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Patients With Brain Metastases From HER2-positive Breast Cancer [Phase 1]
Phase 1 clinical trial update for patients with brain metastases from HER2-positive breast cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Evaluation of Diagnostic Accuracy of Contrast Enhanced Dual Energy Mammography Imaging in Comparison to CE-MRI [NA]
This completed clinical trial evaluated the diagnostic accuracy of Contrast Enhanced Dual Energy Mammography imaging in comparison to contra…
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients [Phase 1]
A Phase 1 study evaluating the safety and preliminary activity of an rHSA/GCSF fusion protein in breast cancer patients with chemotherapy-in…
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Localization of Nonpalpable Breast Lesions [NA]
The clinical trial 'Localization of Nonpalpable Breast Lesions' conducted by Rigshospitalet in Denmark has completed. The update covers cond…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer [Phase 1]
Phase 1 trial evaluating the combination of veliparib with cisplatin and vinorelbine ditartrate in patients with recurrent and/or metastatic…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Intensity Modulated Radiotherapy for Breast Cancer [Phase 1]
A Phase 1 clinical trial evaluating intensity-modulated radiotherapy for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer [Phase 2]
A Phase 2 trial comparing vinorelbine plus everolimus to vinorelbine alone as second-line treatment in Her2-negative breast cancer has compl…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors [Phase 1, Phase 2]
Clinical trial update reporting biomarker changes in a Phase 1/Phase 2 study of synergistic prostaglandin inhibitors for breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Changes in Biomarkers Using Prostaglandin Inhibitors [Phase 1, Phase 2]
Phase 1/2 trial evaluating prostaglandin inhibitors in breast cancer reports biomarker changes; study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy [Phase 2]
Phase 2 trial assessing fluocinonide cream to relieve vaginal dryness and painful intercourse in breast cancer patients undergoing hormone t…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer [Phase 1]
A Phase 1 trial combining crizotinib and sunitinib for metastatic breast cancer has been terminated.